A clinical research lab in Leiden, on a monthly retainer, announced phase-two trial results under embargo. The embargo time was fixed on Tuesday and every figure was checked with the lab twice.
Hannah wrote a one-page plain-language note so health reporters could describe the findings accurately without overstating them.
